» Authors » Laurent Dercle

Laurent Dercle

Explore the profile of Laurent Dercle including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 119
Citations 2796
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Howell H, McGale J, Choucair A, Shirini D, Aide N, Postow M, et al.
Semin Nucl Med . 2025 Feb; PMID: 39966029
Artificial intelligence (AI) has become a pivotal tool for medical image analysis, significantly enhancing drug discovery through improved diagnostics, staging, prognostication, and response assessment. At a high level, AI-driven image...
2.
McGale J, Khurana S, Howell H, Nakhla A, Roa T, Doshi P, et al.
Clin Nucl Med . 2025 Jan; 50(3):e138-e145. PMID: 39780367
Breast cancer presents a significant global health challenge, necessitating continued innovation in diagnostic and therapeutic approaches. Recent advances have led to the identification of cancer-associated fibroblasts, which are highly prevalent...
3.
Zhao B, Dercle L, Yang H, Riely G, Kris M, Schwartz L
Sci Data . 2024 Nov; 11(1):1259. PMID: 39567508
Quantitative imaging biomarkers (QIB) are increasingly used in clinical research to advance precision medicine approaches in oncology. Computed tomography (CT) is a modality of choice for cancer diagnosis, prognosis, and...
4.
Yeh R, Kuo J, Huang B, Shobeiri P, Lee J, Tay Y, et al.
Eur Radiol . 2024 Oct; 35(3):1325-1336. PMID: 39476058
Purpose: To train and validate machine learning-derived clinical decision algorithm (CDA) for the diagnosis of hyperfunctioning parathyroid glands using preoperative variables to facilitate surgical planning. Methods: This retrospective study included...
5.
Beddok A, Orlhac F, Rozenblum L, Calugaru V, Crehange G, Dercle L, et al.
Cancer Radiother . 2024 Oct; 28(6-7):597-602. PMID: 39406602
Purpose: This review systematically investigates the role of radiomics in radiotherapy, with a particular emphasis on the use of quantitative imaging biomarkers for predicting clinical outcomes, assessing toxicity, and optimizing...
6.
Sajan A, Lamane A, Baig A, Floch K, Dercle L
Oncotarget . 2024 Sep; 15:635-637. PMID: 39288288
The emergence of immunotherapy (IO), and more recently intratumoral IO presents a novel approach to cancer treatment which can enhance immune responses while allowing combination therapy and reducing systemic adverse...
7.
McGale J, Liao M, Lopci E, Marabelle A, Dercle L
Oncotarget . 2024 Aug; 15:588-589. PMID: 39186000
Artificial intelligence (AI) is revolutionizing society and healthcare, offering new possibilities for precision medicine. Immunotherapy in oncology (IO) has similarly transformed cancer treatment through novel mechanisms of therapeutic action, but...
8.
Abenavoli E, Linguanti F, Dercle L, Berti V, Lopci E
PET Clin . 2024 Jul; 19(4):505-513. PMID: 38969565
The Food and Drug Administration and the European Medicines Agency have recently approved chimeric antigen receptor-engineered (CAR) T cells to treat several refractory/relapsed B-cell lymphomas. This comprehensive review aims to...
9.
McGale J, Howell H, Beddok A, Tordjman M, Sun R, Chen D, et al.
Pharmaceuticals (Basel) . 2024 Feb; 17(2). PMID: 38399425
The integration of artificial intelligence (AI) and positron emission tomography (PET) imaging has the potential to become a powerful tool in drug discovery. This review aims to provide an overview...
10.
McGale J, Chen D, Trebeschi S, Farwell M, Wu A, Cutler C, et al.
Eur Radiol . 2024 Feb; 34(9):5829-5841. PMID: 38355986
Objective: Immunotherapy has dramatically altered the therapeutic landscape for oncology, but more research is needed to identify patients who are likely to achieve durable clinical benefit and those who may...